Patents by Inventor Gary Paterson

Gary Paterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10061948
    Abstract: A radio frequency identification (RFID) network is presented including a plurality of medical devices each including an RFID transponder and a single RFID transponder emulator configured to emulate functionality of each of the RFID transponders of the plurality of medical devices. The RFID network further includes a plurality of RFID interrogation devices configured to operatively communicate with the single RFID transponder emulator. The single RFID transponder emulator is used for development, testing, evaluation, and validation of each of the plurality of RFID interrogation devices.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: August 28, 2018
    Assignee: COVIDIEN LP
    Inventors: Jeffrey L. Jensen, William Gary Paterson, Erich M. Velandia, Paul E. Ourada
  • Publication number: 20160055359
    Abstract: A radio frequency identification (RFID) network is presented including a plurality of medical devices each including an RFID transponder and a single RFID transponder emulator configured to emulate functionality of each of the RFID transponders of the plurality of medical devices. The RFID network further includes a plurality of RFID interrogation devices configured to operatively communicate with the single RFID transponder emulator. The single RFID transponder emulator is used for development, testing, evaluation, and validation of each of the plurality of RFID interrogation devices.
    Type: Application
    Filed: July 22, 2015
    Publication date: February 25, 2016
    Inventors: JEFFREY L. JENSEN, WILLIAM GARY PATERSON, ERICH M. VELANDIA, PAUL E. OURADA
  • Publication number: 20070074295
    Abstract: There are provided isolated polynucleotide fragments for use in diagnosing and/or developing treatments for schizophrenia. Further provided is a method for diagnosing schizophrenia using one or more polynucleotides disclosed herein. Also provided is a method for screening a compound which regulates expression of a schizophrenia-related gene. Also provided is a chronic animal model of schizophrenia that mimics the functional deficits observed in patients and methods for producing the animal model comprising the administration of PCP to the animal.
    Type: Application
    Filed: September 11, 2006
    Publication date: March 29, 2007
    Applicant: Mitsubishi Pharma Corporation
    Inventors: Susan Cochran, Gary Paterson, Yoshitaka Ohashi, Brian Morris, Judith Pratt
  • Publication number: 20030175741
    Abstract: There are provided isolated polynucleotide fragments for use in diagnosing and/or developing treatments for schizophrenia. Further provided is a method for diagnosing schizophrenia using one or more polynucleotides disclosed herein. Also provided is a method for screening a compound which regulates expression of a schizophrenia-related gene. Also provided is a chronic animal model of schizophrenia that mimics the functional deficits observed in patients and methods for producing the animal model comprising the administration of PCP to the animal.
    Type: Application
    Filed: April 29, 2003
    Publication date: September 18, 2003
    Inventors: Susan Cochran, Gary Paterson, Yoshitaka Ohashi, Brian Morris, Judith Pratt